September is Prostate Cancer Awareness Month. Prostate cancer is the second most common cancer among men, and 1 in 9 men will be diagnosed with prostate cancer during their lifetime. Prostate cancer is the leading site of new cancers diagnosed and the number two cause of death for males. ...
Prostate Cancer Awareness Month is observed every year in September by health experts, health advocates, and the public to raise awareness about prostate health and prostate cancer. This cancer mainly affects men over the age of 50. Every year more than 174,600 men are diagnosed and about 31,...
Prostate Cancer MonthTara Gidus
The prostate cancer condition center is a comprehensive resource for cancer news & oncologist insights on prostate cancer. Read more about cancer at CURE.
September Is Prostate Cancer Awareness MonthMorning, James
Prostate cancer is a major disease that threatens men’s health. Its rapid progression, easy metastasis, and late castration resistance have brought obstacles to treatment. It is necessary to find new effective anticancer methods. Ferroptosis is a novel
Metastatic castration resistant prostate cancer, M0CRPC: non-metastatic castration resistant prostate cancer, mon: month, ORR: Objective response rate, OS: overall survival, PSA: prostate specific antigen, PSA50: PSA decline ratio > 50%, PSA90: PSA decline ratio > 90%, PFS: progressio...
Ejaculation frequency was assessed by asking participants to report the average number of ejaculations they had per month during the ages of 20 to 29 years, 40 to 49 years, and during the past year (1991). Main Outcome Measure Incidence of total prostate cancer....
MYC drives the tumorigenesis of human cancers, including prostate cancer (PrCa), thus deubiquitinase (DUB) that maintains high level of c-Myc oncoprotein is a rational therapeutic target. Several ubiquitin-specific protease (USP) family members of DUB have been reported to deubiquitinate c-Myc, bu...
53,55,57 Within approximately 1 month of biopsy within a UK cohort (n = 1147),53 7.3% of men experienced moderate or serious pain and 5.5% experienced moderate or severe fevers. Prostate biopsy has not been associated with statistically significantly increased risk of death.47,52,53 ...